Please provide your email address to receive an email when new articles are posted on . A novel TAVR system was safe and effective for adults with severe aortic regurgitation who are not surgical ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- ...

SAN FRANCISCO — Among patients with symptomatic, severe native aortic regurgitation at high surgical risk, the JenaValve Trilogy transcatheter heart valve system (JenaValve Technology) met its primary ...

SAN FRANCISCO, CA—The Trilogy heart valve system (JenaValve) performs well in patients who have symptomatic aortic regurgitation (AR) and a high surgical risk, according to the results of the ALIGN-AR ...

NEW YORK, NY—For patients with pure native aortic regurgitation (AR) who are undergoing TAVI, use of devices tailored to treat the AR seems to provide superior outcomes compared with off-label use of ...

Among young adults with aortic regurgitation (AR), those undergoing aortic valve replacement (AVR) before they met standard criteria were more likely to achieve good results from the surgery, a study ...

• The condition of predominant moderate aortic regurgitation could be ameliorated with the rheumatic mitral valve (MV) surgery. What is known and what is new? • During MV surgery, aortic valve ...

Please provide your email address to receive an email when new articles are posted on . Patients with moderate to severe aortic stenosis appear to have outcomes just as poor as those with severe ...

Some dopamine agonists (pergolide [Permax] or cabergoline [Dostinex]) used to treat Parkinson’s disease may be associated with cardiac-valve regurgitation, based on a case-control study (N Engl J Med.